Healthline
April 19, 2025
Share on PinterestMany plant-based proteins are less digestible and may have lower concentrations of one or more essential amino acids. Kseniya Ovchinnikova/Getty Images Vegans who meet […]
April 19, 2025
Share on PinterestNew research suggests an early intervention with two common, low cost drugs could be lifesaving after a heart attack. PixelCatchers/Getty Images A new study […]
April 18, 2025
Share on PinterestHealth agencies and experts recommend fluoride in drinking water at low levels (currently 0.7 mg/L in the U.S.) to promote dental health. LukaTDB/Getty Images […]
April 18, 2025
Share on PinterestA new study found linked to CT scans to increased cancer risk, but the overall risk remains low. Reza Estakhrian/Getty Images A new study […]
Medscape
April 21, 2025
New data documented dramatic shifts in prescribing for both type 2 diabetes (T2D) and weight loss, particularly with the uptake of tirzepatide (Lilly) and declines in […]
April 21, 2025
CHICAGO — For patients with advanced heart failure, an injection of autologous mononuclear cells into damaged myocardia missed the primary endpoint in the sham-controlled, randomized, blinded […]
April 21, 2025
A recently released statement on Trump administration’s drug policy priorities called for a focus on stopping illicit drugs from coming into the United States, prosecuting those […]
April 21, 2025
ORLANDO, Florida — Two lasers developed specifically to target the sebaceous gland were cleared by the US Food and Drug Administration (FDA) for the treatment of […]
FDA
April 18, 2025
Summary Company Announcement Date: April 18, 2025 FDA Publish Date: April 18, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Product may contain an […]
April 16, 2025
Date: May 15, 2025 Time: 9:00 a.m. – 4:30 p.m. ET Organized By: Contributor: Contributor After much consideration, we are postponing the Interested Parties Meeting: Implementation […]
April 16, 2025
Summary Company Announcement Date: October 31, 2023 FDA Publish Date: November 01, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Insanitary manufacturing conditions Company […]
April 16, 2025
FDA has reevaluated the rationale document entitled, “Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa” (MR15, January 2024), submitted by the Clinical and Laboratory Standards Institute (CLSI) to susceptibility […]
